A. ONAT Et Al. , "High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA-I Dysfunctionality," LIPIDS , vol.48, no.1, pp.51-61, 2013
ONAT, A. Et Al. 2013. High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA-I Dysfunctionality. LIPIDS , vol.48, no.1 , 51-61.
ONAT, A., Can, G., ORNEK, E., Ayhan, E., Erginel-Unaltuna, N., & MURAT, S. N., (2013). High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA-I Dysfunctionality. LIPIDS , vol.48, no.1, 51-61.
ONAT, Altan Et Al. "High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA-I Dysfunctionality," LIPIDS , vol.48, no.1, 51-61, 2013
ONAT, Altan Et Al. "High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA-I Dysfunctionality." LIPIDS , vol.48, no.1, pp.51-61, 2013
ONAT, A. Et Al. (2013) . "High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA-I Dysfunctionality." LIPIDS , vol.48, no.1, pp.51-61.
@article{article, author={Altan ONAT Et Al. }, title={High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA-I Dysfunctionality}, journal={LIPIDS}, year=2013, pages={51-61} }